Detalles de la búsqueda
1.
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.
N Engl J Med
; 383(14): 1317-1327, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32865373
2.
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
N Engl J Med
; 381(6): 531-542, 2019 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31390500
3.
Relationships between circulating 25(OH) vitamin D, leptin levels and visceral adipose tissue volume: results from a 1-year lifestyle intervention program in men with visceral obesity.
Int J Obes (Lond)
; 44(2): 280-288, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30926948
4.
Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women.
Am J Physiol Endocrinol Metab
; 314(5): E448-E456, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29208612
5.
Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia.
Am J Physiol Endocrinol Metab
; 315(4): E460-E468, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29870675
6.
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
N Engl J Med
; 372(16): 1489-99, 2015 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773378
7.
Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe.
Clin Chem
; 64(2): 355-362, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038147
8.
Impact of lipoprotein apheresis with dextran-sulfate adsorption on the expression of genes involved in cardiovascular health in the blood of patients with homozygous familial hypercholesterolemia.
J Clin Apher
; 33(1): 104-107, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28712132
9.
Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss.
Am J Physiol Endocrinol Metab
; 312(4): E273-E281, 2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28028035
10.
The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels.
Lipids Health Dis
; 16(1): 119, 2017 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28619117
11.
Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet
; 385(9983): 2153-61, 2015 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25743173
12.
Changes in circulating vitamin D levels with loss of adipose tissue.
Curr Opin Clin Nutr Metab Care
; 19(6): 464-470, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27537278
13.
Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia.
J Clin Apher
; 31(4): 359-67, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26011648
14.
Adiposity, lifestyle and vitamin D levels: the quest for answers.
Int J Obes (Lond)
; 44(7): 1628-1629, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32439910
15.
Long-Term Improvement in Cardiorespiratory Fitness Ameliorates Insulin Sensitivity beyond Changes in Visceral/Ectopic Fat among Men with Visceral Obesity.
Nutrients
; 16(9)2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38732623
16.
No benefit of vitamin D supplementation on muscle function and health-related quality of life in primary cardiovascular prevention patients with statin-associated muscle symptoms: A randomized controlled trial.
J Clin Lipidol
; 18(2): e269-e284, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38177036
17.
Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment.
Eur J Prev Cardiol
; 31(3): 302-310, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855448
18.
Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia.
J Clin Lipidol
; 18(2): e189-e196, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38281851
19.
The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
Circulation
; 136(9): 880-882, 2017 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28847800
20.
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial.
Lancet
; 380(9836): 29-36, 2012 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22633824